REPORTS OF INVESTIGATION
EIZURE induces abrupt changes both in systemic and cerebral hemodynamics. The systemic hyperdynamic response was thought to originate from sympathetic stimulation and excessive catecholamines release. 1 Cerebral hyperemia was considered to be a result of increased brain metabolism and by the augmented perfusion pressure, secondary to the high systemic blood pressure. It is difficult to study the fundamental mechanism of the cerebral circulatory changes in man, because it is ethically unacceptable to evoke seizure attacks in humans.
Electroconvulsive therapy (ECT) is prescribed for patients suffering from depression or other types of psychological disorders resistant to drug therapy. This type of therapeutic convulsion also induces abrupt changes in systemic and cerebral hemodynamics, comparable to other types of seizure. The use of muscular relaxants and management by anesthesiologists has made the therapy safe and reliable. 1 -2 This treatment is an appropriate clinical model for the investigation of the cerebral circulatory physiology of seizure.
Complications secondary to the hemodynamic changes may be fatal and include myocardial infarction and cardiac rupture. [3] [4] In order to prevent the systemic hemodynamic alterations, anti-arrhythmic and antihypertensive drugs have been employed in clinical settings. 1 Such drugs include sodium nitroprusside, trimethaphan, hydralazine, nitroglycerin, clonidine and propranolol. 1, [5] [6] Although these drugs are reported to be effective in attenuating the systemic hypertensive episode, no study has examined the effect of systemic hemodynamic stabilization by antihypertensive drugs on cerebral hyperdynamics after the electrically induced seizure.
There are several reports of considerable changes in cerebral hemodynamics induced by ECT. We reported that blood flow velocity in the middle cerebral artery (MCA) is more than doubled by ECT. 7 VollmerHaase et al. reported that the velocity triples after electrical shock when the measurement was performed at bilateral middle cerebral artery simultaneously. 8 Using a direct measurement of cerebral blood flow by the 133 Xe clearance method, Broderson et al. demonstrated cerebral hyperemia following ECT. 9 We have also demonstrated temporary cerebral hyperemia after electrical shock by utilizing near-infrared spectrophotometry. 10 It is important to examine to what extent systemic hemodynamic stabilization influences the cerebral hemodynamic alterations after electrically induced seizure. Anti-hypertensive medication may reduce cerebral perfusion pressure excessively, so that oxygen delivery is not fulfilled. Moreover, by comparing the effects of anti-hypertensive medications with different pharmacodynamic actions, the underlying mechanism of cerebral hyperemia after seizure might be understood.
The purpose of this study was to identify the effects of anti-hypertensive medications on cerebral circulation, and determine whether systemic blood pressure reduction by the antihypertensive medications disturb the cerebral oxygen demand supply relationship after ECT. We measured MCA flow velocity by transcranial Doppler sonography in ECT patients, and analyzed how pretreatment with antihypertensive drugs influences the cerebral hyperdynamic response after electrical shock. The MCA flow velocity has been reported to reflect cerebral blood flow. 1 1 In addition, oxygen saturation of internal jugular vein blood and blood lactate concentration were examined to assess the oxygen demand and supply relationship after electrically induced seizure under an anti-hypertensive regimen.
Methods
Following approval by the local ethics committee and after obtaining informed consent from the patients or their family, ECT was prescribed to patients suffering from endogenous depression (n=30). Informed consent whether a patient entered this study protocol, was obtained separately after their decision to receive E C T. The patients ranged from 36 to 77 yr (mean ± SD: 58 ± 15) and were in good physical health. No patient had cardiovascular or cerebrovascular complications, or drug allergies. All patients were treated more than six times (three times per week at one-or two-day intervals). Patients who showed blood pressure elevation at the first trial participated in this study. In each of the following five trials (from the second to the fifth), patients received one of the anti-hypertensive medications prior to the electrical shock (immediately after anesthesia induction) by a bolus injection. The doses of drugs were 0.08 mg·kg -1 alprenolol (ALP), 0.01 mg·kg -1 nitroglycerin (NTG), 0.6 µg·kg -1 prostaglandin E1 (PGE1), 0.02 mg·kg -1 nicardipine (NC), or saline (NN), respectively. The order of the anti-hypertensive treatments was determined by a random number table. Drug doses were chosen based on the literature 6,12-13 and on previous clinical experience. [14] [15] The identities of the study drugs were unknown to all persons present at the ECT session. The data obtained during this study were analyzed later by an individual who was also unaware of treatment regimens.
ECT procedures
To avoid an unfavourable parasympathetic reflex, atropine sulfate (0.01 mg·kg -1 ) was prescribed as premedication. 1 Heart rate was monitored by electrocar- Nihon Koden Co. Ltd., Tokyo, Japan), and blood pressure (BP) was measured continuously at the right radial artery using a tonometric BP monitor (CBM-7000; Colin Co. Ltd., Komaki, Japan). The tc-Doppler (TC2-64; EME Co. Ltd., Uberlingen, Germany) probe was adjusted to detect MCA flow from the right temporal side. General anesthesia was induced with 2 mg·kg -1 thiopental and 1 mg·kg -1 succinylcholine. The antihypertensive drug or vehicle solution was injected immediately after the injection of succinylcholine. One minute after the injection, an electrical current was applied bilaterally at the minimal energy level. The electroshock stimulus was delivered by a trained psychologist using an ECT-stimulator (CS-1; Sakai Iryo Co. Ltd., Tokyo, Japan). The efficacy of electrical stimulation was determined by the tourniquet technique, that is, by observing convulsive movements in the distal part of the leg, around which an inflated tourniquet was set to prevent access of muscle relaxant. The P ET CO 2 and arterial blood oxygen saturation (SpO 2 ) were monitored by a respiration monitor (Capnomac Ultima; Datex Co. Ltd., Helsinki, Finland), and P E T CO 2 was maintained at 30-35 mmHg and the SpO 2 (measured at left index) > 98% by manual ventilation assistance throughout the therapy. Blood samples were obtained with 23G needles from the femoral artery and right internal jugular vein immediately after anesthesia induction, and at two and five minutes after electrical shock. Blood gas and lactate concentration were analyzed by a blood gas and electrolyte analyzer (ABL5200-EML105; Radiometer Inc., Copenhagen).
Transcranial Doppler ultrasonography
Flow velocity at the middle cerebral artery was measured using a 2 MHz ultrasonic wave. The Doppler signals were obtained through the right temporal window at a depth of 45-55 mm from the surface. The signal quality was determined from the characteristic high pitched sound and from the wave form of the displayed sonogram. The pulsatility index (PI), which reflect the characteristics of blood flow, was calculated as follows; PI = (systolic velocity -diastolic velocity) / mean velocity. 16 
Data analysis
Data are expressed as mean ± SD. Data were compared using repeated measures two-way analysis of variance. A P value < 0.05 was considered statistically significant. Differences among mean values were analyzed by one-way analysis of variance with Sheffe's post-hoc method.
Results
In the absence of antihypertensive therapy, the alterations in systemic hemodynamics were consistent with previous reports. After a slight decrease in heart rate and blood pressure associated with induction of anesthesia, mean arterial pressure (mBP) and heart rate FIGURE 1 Inhibition of increase in mean arterial blood pressure by all anti-hypertensive medications tested.
FIGURE 2 Heart rate increase modified by anti-hypertensive medication.
(HR) were increased after electrical shock. Both circulatory variables started to increase during application of the electrical shock, reached a maximum value approximately one minute after the shock, continued for about five minutes, and returned to baseline within 10 min. A similar overall hemodynamic pattern was observed under the anti-hypertensive medication regimens. Maximum increase in mean arterial blood pressure was < 20% of the original value in all anti-hypertensive regimens tested (Figure 1 ). Mean blood pressure 0.5, 1, 2 min after electrical shock was lower under anti-hypertensive regimens than under NN (P < 0.01). At three minutes after the shock, mBP under NTG was still less than that under NN. Heart rate was increased by approximately 30% in NN (Figure 2 ). This increase was augmented under NC and PGE1 (P < 0.01 at 1, 2, 3 min after the electrical shock under NC and one minute after the shock under PGE1, P < 0.05 at 0.5, five minutes after the shock under NC and 2, 3, 5,10 min after the shock under PGE1). The increase under PGE1 continued for more than 10 min. Heart rate alteration under NTG was almost identical to that under NN. The HR increase was prevented by APL (P < 0.01 at 1, 2, 3, 5 min after the electrical shock and P < 0.05 at 0.5 min after the shock). Flow velocity at the MCA was more than doubled after electrical shock without treatment, and was not altered by NC or PGE1 (Figure 3 ). This increase was partially prevented by APL and NTG (P < 0.05 at 0.5, 1, two minutes after the shock under APL and 10 min after the shock under NTG, P < 0.01 at 0.5, 1, 2, 3, 5 min after the shock under NTG), but the MCA flow velocity at 0.5, 1, 2 min after the electrical shock under ALP was higher than the pre-shock value (P < 0.05 at two minutes after the shock and P < 0.01 at 0.5, one minute after the shock). Flow velocity under NTG was higher than the pre-shock value at 0.5, one minute after the shock (P < 0.05). The PI in patients without antihypertensive medication was reduced at 0.5 min after the shock and returned to the original value within one minute ( Figure 4) . A similar pattern was observed under APL and PGE1. However, this reduction was not observed under NC and NTG. The PI in patients treated with NC (0.5, 3 min after the shock) and NTG (0.5, 1, 2, 3 min after the shock) was larger than in untreated patients.
Oxygen saturation of internal jugular vein blood increased after ECT with all regimens ( Figure 5 ). The increase in patients treated with NTG and PGE1 was larger than in patients without antihypertensive medication (P < 0.05 at two minutes after the shock under NTG and P < 0.01 at 2, 5 min after the shock under PGE1). Under all of regimens, lactate concentration of internal jugular vein blood increased after the (Table) . However, differences in arterial and venous concentrations were not altered by electrically induced seizure ( Figure 6 ).
Psychological outcomes of these patients assessed by Beck depression inventory scale were not different from those of patients who did not participate in this study. No side effects of the anti-hypertensive drugs were observed.
Discussion

Effect of each anti-hypertensive drug on systemic hemodynamics
Hypertension after an electrically induced seizure has been a concern in anesthetic management of ECT. 1 In the present study, we examined several anti-hypertensive medicines, which have been tested for blood pressure control during ECT anesthesia and reported to be effective. All four anti-hypertensive drugs effectively prevented acute blood pressure increase after electrically induced seizure and their potency on blood pressure was equivalent. The effect on heart rates was different among the drugs. The Ca 2+ antagonist, nicardipine and PGE1, which have vasodilatory actions, induced tachycardia. Alternatively, the ß-adrenergic blocking agent, alprenolol induced relative bradycardia, potentially because of anti-chronotropism. Nitroglycerin had a minor effect on heart rates after electrically induced seizure, and this result was consistent with reports by Nurenberg and Lee. 6 , 1 7 All the antihypertensive drugs tested have different pharmacological characteristics. ß-adrenergic blocking agents prevent a hypertensive response by blocking adrenergic hyperdynamic action on the heart. 1 8 Calcium antagonists dilate vessels by blocking Ca 2 + entry into vascular smooth muscle cells. 1 2 These drugs also prevent spastic vasoconstriction of cerebral arteries. 1 9 PGE1 dilates arteries via prostaglandin receptors on smooth muscle cells. [13] [14] Nitroglycerin is a NO donor, which relaxes smooth muscle through a cyclic GMP-dependent cascade. 6, 13 Several reports describe adrenergic blocking agents as the best choice for blood pressure control during ECT, 1 8 because activation of the adrenergic system is considered a major cause of this phenomenon. However, other anti-hypertensive medicines were also tested and reported to effectively control blood pressure. 11, 20 Although esmolol and labetalol are recently recommended because of their short action, we used alprenolol simply because esmolol and labetalol are not clinically available in the country where this study was performed. 18 Trimethaphan and hydralazine were not examined because they have already been reported to induce prolonged hypotension after electrical shock. 20 
Effect of each anti-hypertensive drug on cerebral hemodynamics
In the present study, administration of anti-hypertensive drugs did not abolish the increase in cerebral blood flow velocity. Even after the administration of anti-hypertensive drugs, flow velocity increased 50 -150%. In addition, the intensity of inhibitory effects on flow velocity increases varied among anti-hypertensive drugs, despite their similar effects on systemic blood pressure. In the present study, the cerebral blood flow velocity after seizure was reduced most in the NTG group. In contrast, a ß-adrenergic blocking agent, alprenolol, decreased the cerebral blood flow velocity temporarily. Since cerebral blood flow velocity is influenced by multiple factors, such as, cardiac output, cerebral perfusion pressure and vessel diameter, 2 1 it seems reasonable that each drug with unique pharmacodynamics, has a distinctive effect on cerebral flow velocity.
In normal subjects, NC is reported to increase cerebral blood flow velocity. 1 2 In contrast, ß-adrenergic blocking agents decrease cerebral blood flow in experimental study. 22 NTG and PGE1 have minimal effects on cerebral blood flow. 13 However, the results of the present study could not be explained by the known action of the drug on cerebral circulation under stable condition. Since the cerebral circulation after electrically induced seizure is thought to be different from that in normal subjects, the action of each drug can be modified by multiple factors. NC and PGE1, which act through receptors or channel proteins blocking, might not have major action on the abrupt cerebral circulatory change after electrically induced seizure. NTG, which is a nitric oxide donor and directly relaxes vascular smooth muscle, might be able to prevent cerebral blood flow velocity increase largely.
In the patients not receiving an anti-hypertensive regimen, PI decreased immediately after the electrical shock and returned to its original value within a few minutes. This observation was consistent with a recent report by Vollmer-Haase. 8 Using transcranial Doppler, they also observed a reduction in PI, 30 sec after electrical shock. Multiple factors may influence PI, such as vascular resistance or cardiac output However, this decrease of PI is considered to indicate dilatation of small resistance arteries. 8 In the present study, NC and NTG altered this pattern. Augmented pulsatility in the systemic circulation and an increase in intracranial pressure, 14, 16 [23] [24] The difference between our results and theirs may be explained because our patients had sympathetic stimulation by ECT and vasodilative action of thiopental sodium, simultaneously.
Oxygen demand and supply ratio after ECT
In this study, internal jugular venous saturation (SjO 2 ) was increased, and the difference in arterial and venous concentrations of lactate was not altered in all groups. The SjO 2 reflects the oxygen demand-supply ratio in brain. 2 5 An increase in this value indicates a surplus supply of oxygen to the brain. Results of the present study suggest that, after electrical shock, blood supply to the brain becomes excessive. Hyperemia is induced by electrical shock, 9-10 and the increased flow may be a primary cause of this alteration which may also result from decreased nervous activity after electrical shock. Metabolic activity of brain is increased temporarily during electrically induced seizure and suppressed one or two minutes after the seizure. 1, 26 After temporary convulsive activity, the electroencephalograph shows low frequency waves implying suppressed nervous activity after the seizure.
Posner et al. demonstrated augmented cerebral metabolism during electrically induced seizures in eight patients. 2 6 They showed that jugular venous carbon dioxide tension increased immediately after the seizure and then returned to the original value within a few minutes. Since the jugular venous oxygen tension increased in the postictal phase, they suggested that the augmented oxygen demand after the seizure must be compensated by the increased cerebral blood flow in the postictal phase. Our findings, in the control group, were consistent with that report. In the present study, NTG and a ß-adrenergic blocking agent partially inhibited the increase in flow velocity. However, the lack of alteration in venous-arterial lactate differences and the increased jugular venous oxygen saturation suggest that cerebral blood flow may still luxurious even in the presence of these drugs. Our data suggest that the increase in cerebral blood flow after electrically induced seizure is more than sufficient for the increase in cerebral oxygen demand, and that moderate inhibition of the cerebral hyperemia after the seizure by some anti-hypertensive agents does not provoke relative ischemia or other untoward effects.
In the present study, we obtained venous blood samples from the jugular vein. For precise analysis, blood sampling from the jugular bulb by introducing a retrograde catheter under fluorographical guidance is recommended. Because blood from the brain is contaminated with extracranial blood when blood is sampled below jugular bulb. However, because of ethical problem, such invasive blood sampling was not accepted in this study. In the ECT patients, subjects are anesthetized and paralyzed. Therefore, metabolism of extracranial tissue is stable. Also, the amount of extracranial blood contamination is limited. Therefore, the alterations in jugular blood mostly reflect the cerebral metabolic change.
In conclusion, cerebral hemodynamics is altered by ECT, even when systemic hemodynamics are stabilized with antihypertensive medication. Although the effects of antihypertensive medicine on cerebral hemodynamics are variable, systemic blood pressure control does not induce cerebral ischemia after ECT. At present, information concerning the relationship between systemic hemodynamics and cerebral circulation, and the physiological mechanisms controlling cerebral circulation after electrically induced seizures, is limited. In the present study, we measured cerebral blood flow velocity at the middle cerebral artery as a parameter of cerebral blood flow. However, the changes in vascular diameter and regional heterogeneity must also be evaluated for complete understanding of cerebral hemodynamics. Further studies with more accurate real time monitoring system may be indispensable to understand the fundamental mechanism of cerebral hyperemia after seizure.
